Metraipolis › archive › dc_2fbcf599a940

Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41194878
DOI
10.3389/fphar.2025.1643557
License (as archived)
solo-consultazione
Archived
2026-11-09T04:09:06.290Z
SHA-256 of the archived text
d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3
Stable URL of this page
https://metraipolis.com/documento/dc_2fbcf599a940

How to cite

Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878 — Europe PMC (en), https://europepmc.org/article/MED/41194878 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fbcf599a940 (Metraipolis archive dc_2fbcf599a940, sha256 d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3)
BibTeX
@misc{dc2fbcf599a940,
  title = {Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41194878},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fbcf599a940; sha256 d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194878. Agents can read the archived copy with the MCP tool read_document.